Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected Findings.
TruSight one sequencing panel
clinical exome sequencing
genetic variants
mutations
next generation sequencing
primary immunodeficiencies
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
26
07
2019
accepted:
16
09
2019
entrez:
5
11
2019
pubmed:
5
11
2019
medline:
31
10
2020
Statut:
epublish
Résumé
Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of genetic defects in PID patients in daily clinical practice. Several NGS approaches are available, from the unbiased whole exome sequencing (WES) to specific gene panels. Here, we report on a 3-year experience with clinical exome sequencing (CES) for genetic diagnosis of PIDs. We used the TruSight One sequencing panel, which includes 4,813 disease-associated genes, in 61 unrelated patients (pediatric and adults). The analysis was done in 2 steps: first, we focused on a virtual PID panel and then, we expanded the analysis to the remaining genes. A molecular diagnosis was achieved in 19 (31%) patients: 12 (20%) with mutations in genes included in the virtual PID panel and 7 (11%) with mutations in other genes. These latter cases provided interesting and somewhat unexpected findings that expand the clinical and genetic spectra of PID-related disorders, and are useful to consider in the differential diagnosis. We also discuss 5 patients (8%) with incomplete genotypes or variants of uncertain significance. Finally, we address the limitations of CES exemplified by 7 patients (11%) with negative results on CES who were later diagnosed by other approaches (more specific PID panels, WES, and comparative genomic hybridization array). In summary, the genetic diagnosis rate using CES was 31% (including a description of 12 novel mutations), which rose to 42% after including diagnoses achieved by later use of other techniques. The description of patients with mutations in genes not included in the PID classification illustrates the heterogeneity and complexity of PID-related disorders.
Identifiants
pubmed: 31681265
doi: 10.3389/fimmu.2019.02325
pmc: PMC6797824
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2325Informations de copyright
Copyright © 2019 Rudilla, Franco-Jarava, Martínez-Gallo, Garcia-Prat, Martín-Nalda, Rivière, Aguiló-Cucurull, Mongay, Vidal, Solanich, Irastorza, Santos-Pérez, Tercedor Sánchez, Cuscó, Serra, Baz-Redón, Fernández-Cancio, Carreras, Vagace, Garcia-Patos, Pujol-Borrell, Soler-Palacín and Colobran.
Références
Am J Hum Genet. 2012 Oct 5;91(4):713-20
pubmed: 23000145
J Inherit Metab Dis. 2012 Jan;35(1):103-14
pubmed: 21748408
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Br J Dermatol. 2016 Feb;174(2):444-8
pubmed: 26288349
Front Immunol. 2018 Dec 14;9:2863
pubmed: 30619256
J Clin Immunol. 2017 Nov;37(8):801-810
pubmed: 28993958
Blood. 2008 Jan 1;111(1):16-24
pubmed: 18156501
J Allergy Clin Immunol. 2010 Dec;126(6):1234-41.e2
pubmed: 20889194
Hum Genet. 2000 Dec;107(6):642-9
pubmed: 11153919
Nature. 2007 Aug 30;448(7157):1058-62
pubmed: 17676033
Nat Genet. 2006 Jan;38(1):93-100
pubmed: 16311595
J Pediatr Genet. 2017 Jun;6(2):61-76
pubmed: 28496993
J Allergy Clin Immunol. 2011 Jul;128(1):226-228.e1
pubmed: 21419480
J Allergy Clin Immunol. 2016 Oct;138(4):1142-1151.e2
pubmed: 27484032
Front Pediatr. 2015 Jan 30;3:2
pubmed: 25688341
J Hum Genet. 2010 Sep;55(9):621-6
pubmed: 20631720
Proc Natl Acad Sci U S A. 1990 Aug;87(16):6171-5
pubmed: 2166947
Front Immunol. 2018 Oct 16;9:2397
pubmed: 30386343
N Engl J Med. 2018 Jan 4;378(1):60-71
pubmed: 29298156
J Clin Invest. 2007 Jun;117(6):1550-7
pubmed: 17492055
Am J Hum Genet. 2009 Aug;85(2):248-53
pubmed: 19631310
Blood Cells Mol Dis. 2012 Mar 15;48(3):154-65
pubmed: 22293322
Cilia. 2015 Jan 22;4(1):2
pubmed: 25610612
Orphanet J Rare Dis. 2010 Jan 29;5:2
pubmed: 20113479
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Pediatr Hematol Oncol. 2005 Dec;22(8):717-21
pubmed: 16251179
Am J Hum Genet. 2012 Apr 6;90(4):689-92
pubmed: 22444670
J Exp Med. 2011 Aug 1;208(8):1635-48
pubmed: 21727188
Clin Rev Allergy Immunol. 2017 Feb;52(1):125-132
pubmed: 28004375
Front Immunol. 2017 Jul 24;8:847
pubmed: 28791010
Blood. 2009 Feb 26;113(9):1967-76
pubmed: 18981294
Biomed Res Int. 2018 May 16;2018:9647253
pubmed: 29888287
J Allergy Clin Immunol. 2010 Sep;126(3):611-7.e1
pubmed: 20816194
Mol Genet Genomic Med. 2016 Feb 24;4(3):359-66
pubmed: 27247962
Clin Immunol. 2011 Oct;141(1):73-82
pubmed: 21664875
J Clin Immunol. 2016 Jan;36(1):73-84
pubmed: 26604104
J Clin Invest. 2014 Aug;124(8):3551-65
pubmed: 24960165
Front Immunol. 2018 Jan 26;8:1965
pubmed: 29434582
Pediatr Blood Cancer. 2014 Jun;61(6):1034-40
pubmed: 24470399
J Clin Immunol. 2018 Apr;38(3):320-329
pubmed: 29675737
Eur J Hum Genet. 2013 Feb;21(2):123-33
pubmed: 22739337
J Allergy Clin Immunol. 2017 Jan;139(1):232-245
pubmed: 27577878
Nat Genet. 2016 Jan;48(1):67-73
pubmed: 26642243
Nature. 2001 May 31;411(6837):599-603
pubmed: 11385576
J Clin Invest. 2014 Sep;124(9):3923-8
pubmed: 25133428
Eur J Pediatr. 1993 May;152(5):406-8
pubmed: 8319706
J Allergy Clin Immunol. 2014 Feb;133(2):529-34
pubmed: 24139496
Front Immunol. 2014 Nov 03;5:531
pubmed: 25404929
Am J Hum Genet. 1989 Feb;44(2):233-40
pubmed: 2912069
N Engl J Med. 2008 May 8;358(19):2030-8
pubmed: 18463379
Am J Clin Dermatol. 2018 Feb;19(1):51-66
pubmed: 28815464
Clin Genet. 2013 Aug;84(2):198-9
pubmed: 23167593
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
Acta Paediatr. 2009 Feb;98(2):408-10
pubmed: 18976358
Trends Immunol. 2019 Jan;40(1):49-65
pubmed: 30509895
Nature. 2006 Nov 2;444(7115):110-4
pubmed: 17080092
Orphanet J Rare Dis. 2010 Dec 08;5:37
pubmed: 21143835
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Dermatol Sci. 2014 May;74(2):99-105
pubmed: 24636350
Am J Hum Genet. 2012 Jun 8;90(6):986-1001
pubmed: 22608502
Int Rev Immunol. 2015;34(6):445-59
pubmed: 26269396
Hum Genet. 1995 Apr;95(4):440-2
pubmed: 7705842
Hum Mol Genet. 2004 Aug 15;13(16):1763-73
pubmed: 15229184
Clin Genet. 2018 Mar;93(3):647-655
pubmed: 29077208
Immunol Res. 2018 Jun;66(3):367-380
pubmed: 29744770
Br J Dermatol. 2015 Jan;172(1):257-61
pubmed: 25041099
Br J Haematol. 2013 Aug;162(3):415-8
pubmed: 23672263
Gene. 2016 Jul 15;586(1):1-6
pubmed: 27050310
J Clin Immunol. 2019 Aug;39(6):577-591
pubmed: 31250335
Hum Mol Genet. 2001 Sep 15;10(19):2171-9
pubmed: 11590134
Hum Mutat. 2018 Jun;39(6):774-789
pubmed: 29527791
Eur J Med Genet. 2017 Oct;60(10):553-558
pubmed: 28774848
J Inherit Metab Dis. 2014 Sep;37(5):831-40
pubmed: 24599607
N Engl J Med. 2007 Oct 18;357(16):1608-19
pubmed: 17881745
Pediatr Blood Cancer. 2012 Apr;58(4):591-7
pubmed: 21548011
J Clin Immunol. 2015 Aug;35(6):527-30
pubmed: 26206677
J Allergy Clin Immunol. 2018 Aug;142(2):702-706.e7
pubmed: 29705242
Nat Genet. 2000 Jun;25(2):141-2
pubmed: 10835624
Am J Hum Genet. 2002 Apr;70(4):845-57
pubmed: 11875755
J Exp Med. 2014 Dec 15;211(13):2537-47
pubmed: 25488983
J Clin Immunol. 2013 Jan;33(1):1-7
pubmed: 22847546
Front Immunol. 2011 Nov 08;2:61
pubmed: 22566850
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
N Engl J Med. 2011 Jul 7;365(1):54-61
pubmed: 21714643
Clin Immunol. 2018 Jun;191:44-51
pubmed: 29572183
Front Immunol. 2019 Apr 11;10:316
pubmed: 31031743
J Allergy Clin Immunol. 2017 Jan;139(1):212-219.e3
pubmed: 27458052
Front Immunol. 2018 May 11;9:1036
pubmed: 29868001
Am J Hum Genet. 2008 Nov;83(5):547-58
pubmed: 18950741
Arch Dis Child. 2014 Sep;99(9):850-6
pubmed: 24771309
Front Immunol. 2016 Nov 07;7:466
pubmed: 27872624
Hum Mutat. 2009 Jul;30(7):1072-81
pubmed: 19370762
Blood. 2011 Nov 24;118(22):5783-93
pubmed: 21931115
J Allergy Clin Immunol. 2009 Sep;124(3):536-43
pubmed: 19683336
N Engl J Med. 2016 Mar 17;374(11):1032-1043
pubmed: 26981933
J Clin Immunol. 2018 Jan;38(1):96-128
pubmed: 29226302
Immunity. 2010 Sep 24;33(3):400-11
pubmed: 20832341
J Allergy Clin Immunol. 2016 Jun;137(6):1780-1787
pubmed: 26915675
Int J Mol Sci. 2016 Dec 09;17(12):
pubmed: 27941691
Nat Genet. 2013 Oct;45(10):1244-1248
pubmed: 23974871
Clin Genet. 2006 Apr;69(4):337-43
pubmed: 16630167
J Dermatol Sci. 2018 Feb;89(2):198-201
pubmed: 29229434
N Engl J Med. 2012 Jan 26;366(4):330-8
pubmed: 22236196
Clin Genet. 2015 Feb;87(2):192-5
pubmed: 24702266
Eur J Dermatol. 1999 Jul-Aug;9(5):354-6
pubmed: 10417436
Am J Hum Genet. 1998 Oct;63(4):1049-59
pubmed: 9758612
J Allergy Clin Immunol. 2016 Oct;138(4):957-969
pubmed: 27720020
J Law Biosci. 2018 Jan 22;4(3):648-657
pubmed: 29868193
Front Immunol. 2014 Apr 16;5:167
pubmed: 24795715